Clover Health Investments (CLOV) Tops Q4 EPS by 3c ; Offers Guidance

Clover Health Investments (NASDAQ: CLOV) reported Q4 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $330.7 million versus the consensus estimate of $348.04 million.

GUIDANCE:

Clover Health Investments sees FY2025 revenue of $1.8-1.87 billion, versus the consensus of $1.62 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Super League Enterprise (SLE) files for 1.07M share offering by selling stockholders
• RH (RH) Tops Q1 EPS by 12c